Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Molecular Pharmaceutics|August 26, 2010
Impact of Biopharmaceutics Classification System-based biowaiversJack A Cook, Barbara M Davit, James E PolliThe AAPS Journal|October 31, 2014
Analysis of imprecision in incurred sample reanalysis for small moleculesSriram Subramaniam, Devvrat Patel, Barbara M Davit, et al.Journal of Clinical Pharmacology|September 3, 2013
Bioequivalence study designs for generic solid oral anticancer drug products: scientific and regulatory considerationsParamjeet Kaur, Chandra S Chaurasia, Barbara M Davit, et al.The AAPS Journal|January 6, 2011
Utility of physiologically based absorption modeling in implementing Quality by Design in drug developmentXinyuan Zhang, Robert A Lionberger, Barbara M Davit, et al.The AAPS Journal|March 5, 2016
BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO RequirementsBarbara M Davit, Isadore Kanfer, Yu Chung Tsang, et al.The AAPS Journal|April 12, 2011
Dissolution testing for generic drugs: an FDA perspectiveOm Anand, Lawrence X Yu, Dale P Conner, et al.Bioanalysis|February 27, 2014
Common bioanalytical deficiencies with bioequivalence submissions in Abbreviated New Drug ApplicationsLeah N Williamson, Dale P Conner, Ethan M Stier, et al.The AAPS Journal|October 26, 2014
Survey of international regulatory bioequivalence recommendations for approval of generic topical dermatological drug productsApril C Braddy, Barbara M Davit, Ethan M Stier, et al.Pharmaceutical Research|August 23, 2012
Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matricesTahseen Mirza, Srikant A Bykadi, Christopher D Ellison, et al.Dermatologic Therapy|May 21, 2009
Generic drugs--safe, effective, and affordableJohn R Peters, Dena R Hixon, Dale P Conner, et al.Pageof 2